These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1812274)

  • 1. Pharmacology of a phosphorus-containing novel angiotensin converting enzyme inhibitor, SQ 29 852 in anesthetized dogs.
    Ohara N; Yokota S; Konishi C; Shukunobe K; Ono H
    J Pharmacobiodyn; 1991 Dec; 14(12):655-62. PubMed ID: 1812274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypotensive effect of a phosphorus-containing novel angiotensin converting enzyme inhibitor, (S)-1-[6-amino-2[[hydroxy(4-phenylbutyl)phosphinyl] oxy]-1-oxohexyl]-L-proline (SQ 29,852) in conscious hypertensive dogs.
    Ohara N; Takizawa M; Yokota S; Ogawa N; Katsumura H; Ono H
    J Pharmacobiodyn; 1992 Jun; 15(6):267-76. PubMed ID: 1432566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: in vitro and preclinical in vivo pharmacology.
    DeForrest JM; Waldron TL; Harvey C; Scalese B; Rubin B; Powell JR; Petrillo EW; Cushman DW
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):730-6. PubMed ID: 2481187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceranapril (SQ 29,852), an orally active inhibitor of angiotensin converting enzyme (ACE).
    DeForrest JM; Waldron TL; Harvey C; Scalese R; Hammerstone S; Powell JR; Karanewsky D
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):121-7. PubMed ID: 1696654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme (ACE). 1. Discovery of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L -proline a novel orally active inhibitor of ACE.
    Karanewsky DS; Badia MC; Cushman DW; DeForrest JM; Dejneka T; Loots MJ; Perri MG; Petrillo EW; Powell JR
    J Med Chem; 1988 Jan; 31(1):204-12. PubMed ID: 3336020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the mechanism of the hypotensive action of SQ-14225, an angiotensin-converting enzyme inhibitor in anesthetized dogs.
    Jandhyala BS; Nandiwada P; Buckley JP; Lokhandwala MF
    Res Commun Chem Pathol Pharmacol; 1979 Sep; 25(3):429-46. PubMed ID: 228363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypotensive action of angiotensin I converting enzyme inhibitor (SQ 14,225) in nephrectomized dogs.
    Miura K; Abe Y; Yamamoto K
    J Pharmacol Exp Ther; 1982 Jul; 222(1):246-50. PubMed ID: 6177851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.
    Seymour AA; Asaad MM; Lanoce VM; Langenbacher KM; Fennell SA; Rogers WL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):872-83. PubMed ID: 8394922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs.
    Seymour AA; Sheldon JH; Smith PL; Asaad M; Rogers WL
    J Pharmacol Exp Ther; 1994 Apr; 269(1):263-70. PubMed ID: 8169834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypotension induced by inhibition of angiotensin-converting enzyme in pentobarbital-anesthetized dogs.
    Vollmer RR; Boccagno JA; Harris DN; Murthy VS
    Eur J Pharmacol; 1978 Sep; 51(1):39-45. PubMed ID: 212276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of acute hemodynamic effects of MC-838, a new angiotensin-converting enzyme inhibitor, with captopril in anesthetized dogs.
    Noguchi K; Kato T; Sunagawa R; Miyamoto Y; Sakanashi M
    Jpn J Pharmacol; 1986 Mar; 40(3):373-80. PubMed ID: 3012164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition.
    Clappison BH; Anderson WP; Johnston CI
    Kidney Int; 1981 Nov; 20(5):615-20. PubMed ID: 6283229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responses of renal, coronary and vertebral vasculatures to MC-838 and captopril in anesthetized dogs.
    Noguchi K; Kato T; Sunagawa R; Sakanashi M
    Pharmacology; 1987; 34(1):48-56. PubMed ID: 3033709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of angiotensin-converting enzyme by SQ 14,225 in anesthetized dogs: hemodynamic and renal vascular effects.
    Murthy VS; Waldron TL; Goldberg ME
    Proc Soc Exp Biol Med; 1978 Jan; 157(1):121-4. PubMed ID: 202968
    [No Abstract]   [Full Text] [Related]  

  • 15. Antihypertensive activity during inhibition of neutral endopeptidase and angiotensin converting enzyme.
    Seymour AA; Swerdel JN; Abboa-Offei B
    J Cardiovasc Pharmacol; 1991 Mar; 17(3):456-65. PubMed ID: 1711608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of the angiotensin II receptor blocker EXP 3174 and of the angiotensin-converting enzyme inhibitor captopril on renal glomerular hemodynamics in the dog.
    Heller J; Kramer HJ; Horácek V
    Kidney Blood Press Res; 1997; 20(6):391-7. PubMed ID: 9453450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of angiotensin-converting enzyme modulates the autoregulation of regional cerebral blood flow in hypertensive rats.
    Sadoshima S; Nagao T; Ibayashi S; Fujishima M
    Hypertension; 1994 Jun; 23(6 Pt 1):781-5. PubMed ID: 8206577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SQ 27,786 and SQ 28,853: two angiotensin converting enzyme inhibitors with potent diuretic activity.
    DeForrest JM; Waldron TL; Powell JR; Floyd DM; Sundeen JE
    J Cardiovasc Pharmacol; 1987 Feb; 9(2):154-9. PubMed ID: 2435992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin converting enzyme inhibitors attenuate ischemic brain metabolism in hypertensive rats.
    Sadoshima S; Fujii K; Ooboshi H; Ibayashi S; Fujishima M
    Stroke; 1993 Oct; 24(10):1561-6; discussion 1566-7. PubMed ID: 8378962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the novel orally active angiotensin converting enzyme inhibitor alacepril on cardiovascular system in experimental animals.
    Takeyama K; Minato H; Nakatsuji K; Suzuki H; Nose I; Oka M; Hosoki K; Hatano N; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):69-73. PubMed ID: 3513779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.